Related Experiment Video
Updated: May 16, 2026
10:01
Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
Published on: July 10, 2012
Peripheral bronchopathia osteochondroplastica.
Majid Mirsadraee1, Mehrdad Katebi
1*Department of Pulmonary Medicine, Islamic Azad University of Mashhad †Department of Pathology, Razavi Hospital, Mashhad, Iran.
Journal of Bronchology & Interventional Pulmonology
|November 22, 2012
Summary
Tracheobronchopathia osteochondroplastica, a rare condition, typically affects large airways. This case highlights a unique peripheral presentation in the bronchioles, previously unreported in medical literature.
Area of Science:
- Pulmonology
- Pathology
- Radiology
Background:
- Tracheobronchopathia osteochondroplastica (TO) is characterized by abnormal bone or cartilage in the trachea/bronchi.
- It typically presents with exophytic lesions covered by normal mucosa.
- Peripheral TO is exceedingly rare, with limited documented cases.
Purpose of the Study:
- To report a unique case of peripheral Tracheobronchopathia osteochondroplastica.
- To describe the clinical, radiological, and histological findings of this rare presentation.
- To contribute to the understanding of TO's varied manifestations.
Main Methods:
- Case report of a 51-year-old male with exertional dyspnea.
- Diagnostic imaging including chest X-ray and CT scan.
- Bronchoscopy with transbronchial lung biopsy for histological examination.
Main Results:
- Imaging revealed diffuse bilateral micronodular pulmonary infiltrate.
- Bronchoscopy showed normal mucosal appearance.
- Histology confirmed discrete cartilaginous nodules in bronchiole walls, indicative of peripheral TO.
Conclusions:
- This case represents a previously unreported peripheral manifestation of Tracheobronchopathia osteochondroplastica.
- Peripheral TO can present with subtle or normal-appearing airways on bronchoscopy.
- Further research is needed to understand the full spectrum and diagnostic challenges of peripheral TO.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...